You have 9 free searches left this month | for more free features.

mirdametinib

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)

Not yet recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +3 more
  • Mirdametinib
  • (no location specified)
Nov 22, 2023

Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

Recruiting
  • Low-Grade Glioma
  • +2 more
  • Mirdametinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 24, 2022

Advanced Solid Tumor Trial in Australia, United States (Mirdametinib, BGB-3245)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +5 more
Jan 26, 2023

Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer Trial in United States (Mirdametinib, Fulvestrant)

Recruiting
  • Breast Cancer
  • +6 more
  • Middletown, New Jersey
  • +3 more
Dec 28, 2021

Solid Tumor, Adult Trial in Australia, United States (Lifirafenib, mirdametinib)

Recruiting
  • Solid Tumor, Adult
  • Santa Monica, California
  • +5 more
Feb 22, 2022

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023